首页> 外国专利> HLA-DMA, CD24 and SDFR1, the markers for diagnosing hepatocellular carcinoma, a kit comprising the same and method for predicting hepatocellular carcinoma using the markers

HLA-DMA, CD24 and SDFR1, the markers for diagnosing hepatocellular carcinoma, a kit comprising the same and method for predicting hepatocellular carcinoma using the markers

机译:HLA-DMA,CD24和SDFR1,用于诊断肝细胞癌的标志物,包含该标志物的试剂盒以及使用该标志物预测肝细胞癌的方法

摘要

The present invention is at least one polynucleotide selected from the group consisting of three polynucleotide of Figure 4 markers for diagnosing lung cancer , including , using a microarray and kit , the marker comprising them and provides a method for predicting the liver . According to the invention , the marker may be used to study the tumorigenesis of lung cancer , it is determined to be able to greatly contribute to early diagnosis of liver cancer .
机译:本发明是选自用于诊断肺癌的图4的三种多核苷酸标记物中的至少一种多核苷酸,包括使用微阵列和试剂盒,包括它们的标记,并提供了预测肝脏的方法。根据本发明,该标记物可用于研究肺癌的肿瘤发生,据确定能够大大有助于肝癌的早期诊断。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号